11C-diprenorphine binding in Huntington's disease: A comparison of region of interest analysis with statistical parametric mapping

Journal of Cerebral Blood Flow and Metabolism

Volumn 17, Issue 9, 1997, Pages 943-949

  Weeks, Robert A ^a   Cunningham, Vincent J ^a   Piccini, Paola ^a   Waters, Simon ^a   Harding, Anita E ^b   Brooks, David J ^a,b  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Huntington's disease; Opioid receptors; PET; Spectral analysis; Statistical parametric mapping; Tracer kinetics

Indexed keywords

CARBON 11; DIPRENORPHINE; OPIATE RECEPTOR; TRACER; NARCOTIC ANTAGONIST;

ADULT; ANALYTIC METHOD; ARTICLE; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUNTINGTON CHOREA; INTERMETHOD COMPARISON; INTRAVENOUS DRUG ADMINISTRATION; KINETICS; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; RECEPTOR BINDING; SPECTROSCOPY; AGED; BRAIN; COMPUTER ASSISTED EMISSION TOMOGRAPHY; METABOLISM; MIDDLE AGED; PATHOLOGY; RADIOGRAPHY;

ADULT; AGED; BRAIN; DIPRENORPHINE; FEMALE; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; NARCOTIC ANTAGONISTS; RECEPTORS, OPIOID; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030612620     PISSN: 0271678X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004647-199709000-00003     Document Type: Article

References (32)

1. Albin RL, Reiner A, Anderson KD, et al (1992) Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease. Ann Nuerol 31:425-430
2. Bruyn GW, Bots GT, Dom R (1979) Huntington's chorea: current neuropathological status. In: Huntington's Disease (Chase TN, Wexler NS, Barbeau A, eds), New York, Raven Press, pp 83-93
3. Cherry SR, Woods RP, Hoffman EJ, et al (1993) Improved detection of focal cerebral blood flow changes using 3D positron emission tomography. J Cereb Blood Flow Metab 13:630-638
4. Cunningham VJ, Ashburner J, Byrne H, Jones T (1993) Use of spectral analysis to obtain parametric images from dynamic PET studies. In: Quantification of Brain Function (Uemura K, Lassen NA, Jones T, Kanno I, eds), New York, Excerpta Medica, pp 101-108
5. Cunningham VJ, Hume SP, Price GR, et al (1991) Compartmental analysis of diprenorphine binding in the rat in vivo and its comparison with equilibrium data in vitro. J Cereb Blood Flow Metab 11:1-9
6. Cunningham VJ, Jones T (1993) Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 13:15-23
7. Cudkowicz M, Kowall NW (1990) Degeneration of pyramidal projection neurons in Huntington's disease cortex. Ann Neurol 27:200-204
8. Dom R, Malfroid M, Baro F (1976) Neuropathology of Huntington's disease: cytometric studies of the ventrobasal complex of the thalamus. Neurology 26:64-68
9. Frey KA, Minoshima S, Koeppe MR, et al (1996) Stereotaxic summation analysis of human cerebral benzodiazepine binding maps. J Cereb Blood Flow Metab 16:409-417
10. Friston KJ, Frackowiak RSJ (1991) Imaging functional anatomy. In: Brain Work and Mental Activity (Lassen NA, Ingvar DH, Raichle ME, Friberg L, eds), Copenhagen, Munksgaard, pp 267-277
11. Frost JJ, Wagner HN, Dannals RF (1985) Imaging opioid receptors in the human brain with positron tomography. J Cereb Blood Flow Metab 9:231-236
12. Goodman RR, Adler BA, Pasternak GW (1988) In: The Opioid Receptors, New Jersey, Humana Press, pp 197-228
13. Grootoonk S, Spinks TJ, Jones T, et al (1992) Correction for scatter using a dual energy window technique with a tomograph operated without septa. IEEE Medical Imaging Conf Record 15:741-745
14. Gulya K (1990) The opioid system in neurologic and psychiatric disorders and in their experimental models. Pharmacol Ther 46:395-428
15. Harper PS (1992) The epidemiology of Huntington's disease. Hum Genet 89:365-376
16. 11C-diprenorphine cerebral kinetics in man acquired by PET using presaturation pulse chase and tracer only protocols. J Neurosci Methods 51:123-134
17. Koepp MJ, Richardson MP, Brooks DJ, et al (1996) Cerebral benzodiazepine receptors in hippocampal sclerosis: an objective in vivo analysis. Brain 119:1677-1687
18. 11C] buprenorphine from 3-0-trityl protected precursors. Appl Radiat Isot 45: 857-873
19. Ranicar AS, Williams CW, Schnorr L, et al (1991) The on-line monitoring of continuously withdrawn arterial blood during PET studies using a single BGO/photomultiplier assembly and non-stick tubing. Med Prog Technol 17:259-264
20. Richardson MP, Koepp MJ, Brooks DJ, et al (1996) Benzodiazepine receptors in focal epilepsy with cortical dysgenesis: an 11C-flumazenil PET study. Ann Neurol 40:188-199
21. Robb RA (1990) A software system for interactive and quantitative analysis of biomedical images. In: 3D Imaging in Medicine (Hohne KH, Fuchs H, Pizer SM, eds), New York, NATO ASI Series, pp 333-361
22. Rostene WH, Dubois A, Zajac JM, et al (1988) Changes in opioid, neurotensin receptor density and neutral endopeptidase in Parkinson and Huntington brains. Soc Neurosci Abstr 14:353-350
23. 11C]diprenorphine and positron emission tomography. J Cereb Blood Flow Merab 11:204-219
24. Seizinger BR, Liebisch DC, Kish SJ, et al (1986) Opioid peptides in Huntington's disease: alterations in the prodynorphin and proenkehalin system. Brain Res 378:405-408
25. Simpson SA, Harding AE (1993) Predictive testing for Huntington's disease: after the gene. The United Kingdom Huntington's Disease Prediction Consortium. J Med Genet 30:1036-1038
26. Spinks TJ, Tones T, Bailey D, et al (1992) Physical performance of a positron tomograph for brain imaging with retractable septa. Phys Med Biol 37:1637-1655
27. 11C-diprenorphine binding using spectral analysis of dynamic PET images acquired in 3D. In: Quantification of Brain Function (Uemura, Lassen, Jones, Kanno, eds), New York, Excerpta Medica, pp 289-301
28. Talairach J, Tournoux P (1988) Co-planar stereotaxic atlas of the human brain. New York: Thieme
29. Townsend DW, Spinks TJ, Jones T, et al (1989) Fully three-dimensional reconstruction for a PET camera with retractable septa. Eur J Nucl Med 15:741-745
30. 2 receptor binding in patients with Huntington's disease and other choreas: a PET study. Brain 118:689-696
31. Weeks RA, P Piccini, Harding AE, Brooks DJ (1996) PET demonstrates a parallel loss of D1 and D2 dopamine receptors in asymptomatic gene carriers of Huntington's disease. Ann Neurol 40:49-55
32. Woolson RF (1987) Statistical methods for the analysis of biomedical data. New York, Wiley, pp 23-24